The metabolic function of cyclin D3-CDK6 kinase in cancer cell survival.

Nature 2017 06 7;546(7658):426-430. Epub 2017 Jun 7.

Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.

D-type cyclins (D1, D2 and D3) and their associated cyclin-dependent kinases (CDK4 and CDK6) are components of the core cell cycle machinery that drives cell proliferation. Inhibitors of CDK4 and CDK6 are currently being tested in clinical trials for patients with several cancer types, with promising results. Here, using human cancer cells and patient-derived xenografts in mice, we show that the cyclin D3-CDK6 kinase phosphorylates and inhibits the catalytic activity of two key enzymes in the glycolytic pathway, 6-phosphofructokinase and pyruvate kinase M2. This re-directs the glycolytic intermediates into the pentose phosphate (PPP) and serine pathways. Inhibition of cyclin D3-CDK6 in tumour cells reduces flow through the PPP and serine pathways, thereby depleting the antioxidants NADPH and glutathione. This, in turn, increases the levels of reactive oxygen species and causes apoptosis of tumour cells. The pro-survival function of cyclin D-associated kinase operates in tumours expressing high levels of cyclin D3-CDK6 complexes. We propose that measuring the levels of cyclin D3-CDK6 in human cancers might help to identify tumour subsets that undergo cell death and tumour regression upon inhibition of CDK4 and CDK6. Cyclin D3-CDK6, through its ability to link cell cycle and cell metabolism, represents a particularly powerful oncoprotein that affects cancer cells at several levels, and this property can be exploited for anti-cancer therapy.

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature22797DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516959PMC
June 2017
147 Reads

Publication Analysis

Top Keywords

cyclin d3-cdk6
24
cdk4 cdk6
12
cell cycle
8
cancer cells
8
serine pathways
8
levels cyclin
8
tumour cells
8
ppp serine
8
function cyclin
8
d3-cdk6 kinase
8
cyclin
7
d3-cdk6
6
cell
6
turn increases
4
levels
4
glutathione turn
4
nadph glutathione
4
antioxidants nadph
4
increases levels
4
levels reactive
4

References

(Supplied by CrossRef)

M Malumbres et al.
Genome Biol. 2014

CJ Sherr et al.
Cancer Discov. 2016

A Deshpande et al.
Oncogene 2005

JL Dean et al.
Oncogene 2010

M Puyol et al.
Cancer Cell 2010

JL Dean et al.
Cell Cycle 2012

YJ Choi et al.
Cancer Cell 2012

CM Sawai et al.
Cancer Cell 2012

RA Cairns et al.
Nat. Rev. Cancer 2011

HR Christofk et al.
Nature 2008

X Tong et al.
Curr. Opin. Genet. Dev. 2009

Similar Publications